City National Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

City National Bank’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-120,480	Closed	-$1.2M	–	901
2015 Q2	$1.2M	Sell	120,480 -337,142	-74%	-$3.62M	0.01%	458
2015 Q1	$5.83M	Buy	457,622 +107,108	+31%	+$1.38M	0.05%	263
2014 Q4	$4.96M	Buy	350,514 +26,359	+8%	+$408K	0.04%	280
2014 Q3	$4.46M	Buy	324,155 +9,868	+3%	+$151K	0.04%	275
2014 Q2	$4.83M	Buy	314,287 +163,761	+109%	+$2.32M	0.04%	269
2014 Q1	$2.56M	Buy	150,526 +128,930	+597%	+$1.95M	0.04%	275
2013 Q4	$280K	Buy	+21,596	New	+$258K	﹤0.01%	694

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

City National Bank's KERX Position: Q3 2015 in Review

City National Bank sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2015, closing a stake of 120,480 shares — an estimated $1.2M sold.

City National Bank first reported a position in KERX in Q4 2013 and held it in 7 quarters. The position peaked at $5.83M in Q1 2015. 138 funds tracked by Wall St. Rank hold KERX as of Q3 2015.

City National Bank reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
City National Bank sold 120,480 Keryx Biopharmaceuticals Inc shares in Q3 2015, an estimated $1.2M.
City National Bank first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 7 quarters.
City National Bank's Keryx Biopharmaceuticals Inc position peaked at $5.83M in Q1 2015.
138 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.